Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
M L Dahl-Puustinen
Observed names:
M. -L. Dahl-Puustinen,
M.-L. Dahl-Puustinen,
M.L Dahl-Puustinen,
ML Dahl‐Puustinen
Observed institution:
Karolinska Institutet
OpenAlex ID:
A5110181567
Disassociation Between Debrisoquine Hydroxylation Phenotype and Genotype Among Chinese
1989
·
Q.Y Yue
, L Bertilsson
, et al.
·
The Lancet
·
45
Use of prescription forgeries in a drug abuse surveillance network
1989
·
U. Bergman
, M. -L. Dahl-Puustinen
·
European Journal of Clinical Pharmacology
·
22
Glucuronidation of E-10-hydroxynortriptyline in human liver, kidney, and intestine. Organ-specific differences in enantioselectivity.
1989
·
M L Dahl-Puustinen
, E Dumont
, et al.
·
Drug Metabolism and Disposition
·
20
Metrifonate in healthy volunteers: interrelationship between pharmacokinetic properties, cholinesterase inhibition and side-effects.
1990
·
Y Aden-Abdi
, T Villén
, et al.
·
Europe PMC (PubMed Central)
·
16
Lack of relationship between glibenclamide metabolism and debrisoquine or mephenytoin hydroxylation phenotypes.
1990
·
ML Dahl‐Puustinen
, C Alm
, et al.
·
British Journal of Clinical Pharmacology
·
12
PDF
E-10-Hydroxynortriptyline: Effects and Disposition of a Potential Novel Antidepressant
1989
·
L. Bertilsson
, M.-L. Dahl-Puustinen
, et al.
·
Springer eBooks
·
5
Show more works
View as search
Works count:
6
Citation count:
120
H-index:
5
I10-index:
5
Year
Topic
Type
